Drug recall · January 22, 2014
ACETAMINOPHEN/ ASPIRIN/ CAFFEINE recall
Why: Labeling: Label Mixup; ACETAMINOPHEN/ ASPIRIN/ CAFFEINE, Tablet, 250 mg/250 mg/65 mg may be potentially mislabeled as NAPROXEN, Tablet, 500 mg, NDC 53746019001, Pedigree: AD68025_8, EXP: 5/28/2014.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
ACETAMINOPHEN/ ASPIRIN/ CAFFEINE, Tablet, 250 mg/250 mg/65 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904513559
- Lots / codes
ACETAMINOPHEN/ ASPIRIN/ CAFFEINE, Tablet, 250 mg/250 mg/65 mg has the following code Pedigree: AD68022_4, EXP: 5/28/2014.
- Quantity
- 100 Tablets
- Company
- Aidapak Services, LLC, Vancouver, WA
- Distribution
- Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
- Initiated
- July 2, 2013 · Voluntary: Firm initiated
- Classified
- January 16, 2014
- Reported
- January 22, 2014
- Ended
- February 7, 2014
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Aspirin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.